Vektor Medical
Carlsbad, US · Founded 2017 · Delaware corporation · 2 known investors
Find your way into Vektor Medical
288 people in our graph share verified history with the Vektor Medical team — schools, employers, funds. One of them is your warm intro.
Vignesh Ravikumarunlockedknows Chris Villongco · together at Depts. of Medicine and Bioengineering, UCSD (overlapped)
×2knows the team · via United States Court of Appeals for the Sixth Circuit
×2knows the team · via Harvard Law School
×2knows the team · via Depts. of Medicine and Bioengineering, UCSD
knows the team · via The Ohio State University
knows the team · via Lawrence Livermore National Laboratory
Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.
Founders & leadership
Vektor Medical was founded in 2017 by Chris Villongco.
CV
Chris VillongcoinHead of Technology / CTOChris Villongco holds a Ph.D. in Bioengineering with specialization in computational modeling of cardiac physiology and has a background in mechanical engineering. As Head of Technology at Vektor Medical, he oversees development of patient-specific computational models to support diagnosis and treatment of cardiac arrhythmias.
RK
Rob KrummeninCEO (formerly President & COO)Rob Krummen joined Vektor Medical in 2018 as Chief Operating Officer and General Counsel, advancing to President and COO in 2021 before becoming CEO in 2022. He has led the company through funding rounds, regulatory approvals, and product launches in cardiac electrophysiology.
KP
Kelly PerezinHead of Finance
AM
Alexander Michael MonkoNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$32.9M disclosed across 5 rounds · 2018–2024
▶$28.9MraisedFeb 2024 · 98 investors · BiotechnologyRule 506(b)
▶$28.9MraisedFeb 2024 · 98 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joe BraidwoodExecutive Officer
- C. David AdairDirector
- Lana CaronExecutive Officer
- Robert J. KrummenExecutive Officer, Director
- Shannon St. ClairExecutive Officer
- Chris VillongcoExecutive Officer
- Luc MarengereDirector
- Douglas S. KomenExecutive Officer
- Alexander M. MonkoExecutive Officer, Director
- Offering amount
- $37.5M
- Amount sold
- $28.9M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.6MraisedNov 2019 · 22 investors · BiotechnologyRule 506(b)
▶$3.6MraisedNov 2019 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kalle MarsalDirector
- Robert J. KrummenDirector
- Alexander Michael MonkoExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.6M
- Minimum investment
- $25K
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$11.3KraisedJul 2018 · 1 investors · Other Health CareRule 506(b)
▶$11.3KraisedJul 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chris VillongcoExecutive Officer
- Robert J. KrummenExecutive Officer, Director
- Alexander Michael MonkoExecutive Officer, Director
- Offering amount
- $11.3K
- Amount sold
- $11.3K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$12.2KraisedMay 2018 · 1 investors · Other Health CareRule 506(b)
▶$12.2KraisedMay 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert J. KrummenExecutive Officer, Director
- Chris VillongcoExecutive Officer
- Alexander Michael MonkoExecutive Officer, Director
- Offering amount
- $12.2K
- Amount sold
- $12.2K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$370KraisedFeb 2018 · 4 investors · Other Health CareRule 506(b)
▶$370KraisedFeb 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chris VillongcoExecutive Officer
- Alexander Michael MonkoExecutive Officer, Director
- Robert J. KrummenDirector
- Offering amount
- $2.5M
- Amount sold
- $370K
- Proceeds to insiders
- $270K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Vektor Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Vektor Medical do?
- Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.
- Who founded Vektor Medical?
- Vektor Medical was founded by Chris Villongco in 2017.
- Who are Vektor Medical's investors?
- Vektor Medical's investors include Solas BioVentures, TVM Capital Life Science.
- How much funding has Vektor Medical raised?
- Vektor Medical has disclosed $32.9M raised across 5 rounds.
- Where is Vektor Medical headquartered?
- Vektor Medical is headquartered in Carlsbad, US.